These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33009130)

  • 1. Imaging of renal fibrosis.
    Hysi E; Yuen DA
    Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):599-607. PubMed ID: 33009130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could MRI Be Used To Image Kidney Fibrosis? A Review of Recent Advances and Remaining Barriers.
    Leung G; Kirpalani A; Szeto SG; Deeb M; Foltz W; Simmons CA; Yuen DA
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):1019-1028. PubMed ID: 28298435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.
    Bülow RD; Boor P
    J Histochem Cytochem; 2019 Sep; 67(9):643-661. PubMed ID: 31116062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced non-invasive diagnostic techniques for visualization and estimation of kidney fibrosis.
    Srivastava A; Tomar B; Prajapati S; Gaikwad AB; Mulay SR
    Drug Discov Today; 2021 Aug; 26(8):2053-2063. PubMed ID: 33617976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Chronic Renal Tubulointerstitial Injury.
    Bagnasco SM; Rosenberg AZ
    J Histochem Cytochem; 2019 Sep; 67(9):633-641. PubMed ID: 31242044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Renal Fibrosis-Turning Challenges into Opportunities.
    Klinkhammer BM; Goldschmeding R; Floege J; Boor P
    Adv Chronic Kidney Dis; 2017 Mar; 24(2):117-129. PubMed ID: 28284377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis.
    Li J; An C; Kang L; Mitch WE; Wang Y
    Adv Chronic Kidney Dis; 2017 May; 24(3):150-153. PubMed ID: 28501077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal fibrosis: new insights into the pathogenesis and therapeutics.
    Liu Y
    Kidney Int; 2006 Jan; 69(2):213-7. PubMed ID: 16408108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis.
    Sun Q; Baues M; Klinkhammer BM; Ehling J; Djudjaj S; Drude NI; Daniel C; Amann K; Kramann R; Kim H; Saez-Rodriguez J; Weiskirchen R; Onthank DC; Botnar RM; Kiessling F; Floege J; Lammers T; Boor P
    Sci Transl Med; 2019 Apr; 11(486):. PubMed ID: 30944168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperpolarized [1-
    Nielsen PM; Mariager CØ; Mølmer M; Sparding N; Genovese F; Karsdal MA; Nørregaard R; Bertelsen LB; Laustsen C
    Magn Reson Med; 2020 Oct; 84(4):2063-2073. PubMed ID: 32452096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the role and mechanism of Wnt/β-catenin signalling in kidney fibrosis.
    Zuo Y; Liu Y
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():38-43. PubMed ID: 30298654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Therapies for the Treatment of Renal Fibrosis.
    Liu F; Zhuang S
    Adv Exp Med Biol; 2019; 1165():625-659. PubMed ID: 31399988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of extracellular matrix probes and extracellular matrix-related probes for assessing diagnosis and prognosis in renal diseases.
    Eikmans M; Ijpelaar DH; Baelde HJ; de Heer E; Bruijn JA
    Curr Opin Nephrol Hypertens; 2004 Nov; 13(6):641-7. PubMed ID: 15483455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMP-activated protein kinase/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis.
    Wang Y; Jia L; Hu Z; Entman ML; Mitch WE; Wang Y
    Kidney Int; 2018 Jan; 93(1):81-94. PubMed ID: 28739141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.
    Chen DQ; Wang YN; Vaziri ND; Chen L; Hu HH; Zhao YY
    Phytomedicine; 2020 Jul; 72():153232. PubMed ID: 32460034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia causes important changes of extracellular matrix biomarkers and ADAMTS proteinases in the adriamycin-induced renal fibrosis model.
    Armutcu F; Demircan K; Yildirim U; Namuslu M; Yagmurca M; Celik HT
    Nephrology (Carlton); 2019 Aug; 24(8):863-875. PubMed ID: 30719800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.
    Zhou D; Tian Y; Sun L; Zhou L; Xiao L; Tan RJ; Tian J; Fu H; Hou FF; Liu Y
    J Am Soc Nephrol; 2017 Feb; 28(2):598-611. PubMed ID: 27624489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
    Negri AL
    J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-fibrotic treatments: A review of clinical evidence.
    Allinovi M; De Chiara L; Angelotti ML; Becherucci F; Romagnani P
    Matrix Biol; 2018 Aug; 68-69():333-354. PubMed ID: 29654884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis.
    Won S; Davies-Venn C; Liu S; Bluemke DA
    Curr Opin Cardiol; 2013 May; 28(3):282-9. PubMed ID: 23549230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.